W. Kremer

发表

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B

P. Galle, K. Lackner, S. Koch, 2020, BMC Health Services Research.

Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study

P. Galle, M. Bodenstein, C. Labenz, 2021, Journal of cachexia, sarcopenia and muscle.

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis

J. Schattenberg, C. Labenz, M. Wörns, 2022, Diagnostics.

Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis

P. Galle, J. Schattenberg, C. Labenz, 2021, Scientific Reports.

Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection

P. Galle, J. Schattenberg, C. Labenz, 2020, Journal of Investigative Medicine.

Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV

J. Schattenberg, C. Labenz, D. Grimm, 2022, Quality of Life Research.

Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission

P. Galle, K. Lackner, H. Rossmann, 2021, Medical Microbiology and Immunology.

Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany.

J. Schattenberg, C. Labenz, E. Siegel, 2022, Annals of hepatology.

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV

J. Schattenberg, C. Labenz, Y. Huber, 2022, Hepatology communications.

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)

J. Schattenberg, C. Labenz, M. Bros, 2022, Journal of clinical medicine.

Risk factors for poorer health literacy in patients with liver cirrhosis

P. Galle, J. Schattenberg, C. Labenz, 2021, PloS one.

Sarcopenia as prognostic factor for survival after orthotopic liver transplantation

P. Galle, D. Zöller, S. Koch, 2019, European journal of gastroenterology & hepatology.

Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission

P. Galle, K. Lackner, H. Rossmann, 2021, Medical microbiology and immunology.

Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis.

P. Galle, J. Schattenberg, C. Labenz, 2022, Clinics and research in hepatology and gastroenterology.

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis

P. Galle, J. Schattenberg, C. Labenz, 2022, Hepatology communications.

Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis

P. Galle, C. Labenz, M. Wörns, 2020, Clinical and translational gastroenterology.

Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis

P. Galle, J. Schattenberg, C. Labenz, 2020, Alimentary pharmacology & therapeutics.

Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV

J. Schattenberg, C. Labenz, D. Grimm, 2022, Quality of Life Research.

Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis

J. Schattenberg, C. Labenz, M. Wörns, 2022, Clinical and translational gastroenterology.

Metabolic dysfunction-associated fatty liver disease in people living with HIV

J. Schattenberg, C. Labenz, D. Grimm, 2023, Scientific reports.

Evaluation of Sonographic Muscle Measurement Using Established Muscle Markers.

C. Labenz, F. Hahn, V. Sivanathan, 2024, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.